CVS CVS Health Corporation Common Stock
$95,63
Harga · Agu 19, 2026
Fundamental per Agu 5, 2026
Rentang 52M
$70–$111
63% of range
Peringkat Analis
BUY
33 analysts
Target Harga
$116
+21% upside
P/E (TTM)
68.8
ROE
2.4%
Margin Laba Bersih
0.44%
Tentang CVS Health Corporation Common Stock Tinjauan perusahaan dari Wikipedia
CVS Caremark adalah sebuah perusahaan asal Amerika Serikat yang bergerak di industri Farmasi. Saat ini, markas pusat CVS Caremark terletak di 1 CVS Dr., Woonsocket, RI, Amerika Serikat, dan dipimpin oleh CEO Larry J. Merlo.
Baca selengkapnya
CVS Caremark (NYSE: CVS) adalah sebuah perusahaan asal Amerika Serikat yang bergerak di industri Farmasi. Saat ini, markas pusat CVS Caremark terletak di 1 CVS Dr., Woonsocket, RI, Amerika Serikat, dan dipimpin oleh CEO Larry J. Merlo.
Pada tahun 2014, CVS Caremark masuk dalam daftar Fortune 500, sebuah daftar peruahaan berdasarkan pendapatan kotornya yang dibuat oleh majalah Fortune setiap tahunnya. Pada tahun ini CVS Caremark berada dalam peringkat 12 dengan pendapatan sekitar $126.761 juta, keuntungan sebesar $4.592, dan total aset sebesar 71.526.
Fortune mencatat bahwa pada tahun 2013, CVS mengalami peningkatan penjualan sebesar 3% yang berasal dari peningkatan penjualan jasa dan produk-produk retail. CVS melakukan transformasi menjadi penyedia jasa kesehatan. Tindakan ini merupakan respon dari diberlakukannya reformasi perawatan kesehatan oleh pemerinta Amerika Serikat di bawah kepemimpinan Presiden Barrack Obama yang berpengaruh pada meningkatnya jumlah pasien asuransi kesehatan. CVS juga memutuskan untuk menghentikan penjualan produk-produk rokok dan tembakaunya di bulan Oktober 2014.
Referensi
Lihat pula
Fortune 500
New York Stock Exchange
Perusahaan publik
Pranala luar
Situs resmi CVS Caremark
Sumber: Wikipedia, CC BY-SA 4.0 · Lihat di Wikipedia ↗
CVS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$95.63
Kapitalisasi Pasar
$121.55B
P/E (TTM)
68.8
EPS (TTM)
$1.39
Pendapatan (TTM)
$402.07B
Imbal Hasil Dividen
2.8%
ROE
2.4%
D/E Utang/Ekuitas
0.0
Rentang 52M
$70 – $111
CVS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$402.07B
2017-12-31
→
2025-12-31
EPS
$1.39
2017-12-31
→
2025-12-31
Arus Kas Bebas
$7.81B
2017-12-31
→
2025-12-31
Margin
0.44%
2017-12-31
→
2017-12-31
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
CVS
Median Rekan
P/E (TTM)
68.8
42.6
P/S (TTM)
0.3
0.3
P/B
1.6
0.9
EV / EBITDA
12.0
—
Price / FCF (Harga / FCF)
15.6
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
CVS
Median Rekan
Operating Margin (Margin Operasi)
1.2%
—
Net Profit Margin (Margin Laba Bersih)
0.44%
-7.0%
ROA
0.70%
-10.6%
ROE
2.4%
-20.8%
ROIC
5.0%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
CVS
Median Rekan
Debt / Equity (Utang / Ekuitas)
0.0
8.0
Current Ratio (Rasio Lancar)
0.8
1.1
Quick Ratio (Rasio Cepat)
0.6
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
CVS
Median Rekan
Revenue YoY (Pendapatan YoY)
7.8%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
7.6%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
8.4%
—
EPS YoY
-62.0%
—
Net Income YoY (Laba Bersih YoY)
-61.7%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
CVS
Median Rekan
Payout Ratio (Rasio Pembayaran Dividen)
192.1%
—
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Imbal Hasil Dividen
2.8%
Rasio Pembayaran Dividen
192.1%
CAGR Dividen 5T
—
| Tanggal ex-dividen | Jumlah |
|---|---|
| 23 Juli 2026 | $0,6650 |
| 23 April 2026 | $0,6650 |
| 22 Jan. 2026 | $0,6650 |
| 23 Okt. 2025 | $0,6650 |
| 22 Juli 2025 | $0,6650 |
| 22 April 2025 | $0,6650 |
| 23 Jan. 2025 | $0,6650 |
| 21 Okt. 2024 | $0,6650 |
| 22 Juli 2024 | $0,6650 |
| 19 April 2024 | $0,6650 |
| 19 Jan. 2024 | $0,6650 |
| 19 Okt. 2023 | $0,6050 |
| 20 Juli 2023 | $0,6050 |
| 20 April 2023 | $0,6050 |
| 19 Jan. 2023 | $0,6050 |
| 20 Okt. 2022 | $0,5500 |
| 21 Juli 2022 | $0,5500 |
| 21 April 2022 | $0,5500 |
| 20 Jan. 2022 | $0,5500 |
| 21 Okt. 2021 | $0,5000 |
CVS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
33 analis
- Beli Kuat 8 24,2%
- Beli 20 60,6%
- Tahan 5 15,2%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
25 analis · 2026-08-17
Median
$116.00
← Di bawah semua target
$95.63
Rendah
$103.00
Tinggi
$148.00
Target median
$116.00
+21,3%
Target rata-rata
$116.08
+21,4%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.37%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $2.58 | $1.87 | 0.71% |
| 31 Maret 2026 | $2.57 | $2.22 | 0.35% |
| 31 Des. 2025 | $1.09 | $1.00 | 0.09% |
| 30 Sep. 2025 | $1.60 | $1.38 | 0.22% |
| 30 Juni 2025 | $1.81 | $1.47 | 0.34% |
| 31 Maret 2025 | $2.25 | $1.72 | 0.53% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Cost of Revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B | $158.72B | · | $153.45B | $146.53B | $126.76B | |
| Gross Profit | · | · | · | · | · | · | · | · | $28.55B | $28.86B | $26.53B | |
| Operating Expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | · | $18.81B | $18.45B | $17.05B | |
| Operating Income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | · | $9.54B | $10.39B | $9.47B | |
| Interest Expense | · | · | $2.66B | $2.29B | $2.50B | $2.91B | $3.04B | · | $1.06B | $1.08B | $859M | |
| Interest Income | · | · | · | · | · | · | · | · | $21M | $20M | $21M | |
| Other Non-op | $112M | $99M | $88M | $169M | $182M | $206M | $124M | · | $-208M | $-28M | · | |
| Pretax Income | $2.14B | $6.15B | $11.17B | $5.84B | $10.54B | $9.77B | $9.00B | · | $8.27B | $8.64B | $8.62B | |
| Income Tax | $408M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B | $2.37B | · | $1.64B | $3.32B | $3.39B | |
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | · | $6.47 | $4.93 | $4.66 | |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 | |
| Shares (Basic) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 | 1,319,000,000 | 1,309,000,000 | 1,301,000,000 | · | 1,020,000,000 | 1,073,000,000 | 1,118,000,000 | |
| Shares (Diluted) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 | 1,329,000,000 | 1,314,000,000 | 1,305,000,000 | · | 1,024,000,000 | 1,079,000,000 | 1,126,000,000 | |
| EBITDA | $9.27B | $13.11B | $18.11B | $11.99B | $17.70B | $18.35B | $16.36B | · | $12.00B | $10.34B | $9.45B |
Neraca 31
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B | $7.85B | $5.68B | · | $1.70B | $3.37B | $2.46B | |
| Short-term Investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B | $3.00B | $2.37B | · | $111M | $87M | $88M | |
| Receivables | $39.78B | $36.47B | $35.23B | $27.28B | $24.43B | $21.74B | $19.62B | · | $13.18B | $12.16B | $11.89B | |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | $17.76B | $18.50B | $17.52B | · | $15.30B | $14.76B | $14.00B | |
| Other Current Assets | $5.09B | $3.08B | $3.15B | $2.64B | $5.29B | $5.28B | $5.11B | $4.53B | $945M | $660M | $722M | |
| Current Assets | $74.71B | $68.64B | $67.86B | $65.63B | $60.01B | $56.37B | $50.30B | $45.20B | $31.23B | $31.04B | $29.16B | |
| PP&E (Net) | · | · | · | $12.87B | $12.90B | $12.61B | $12.04B | $11.36B | $10.29B | $10.18B | $9.86B | |
| PP&E (Gross) | · | · | · | $34.60B | $33.55B | $31.31B | $28.93B | · | $24.29B | $22.80B | $21.04B | |
| Accum. Depreciation | · | · | · | $21.48B | $20.65B | $18.70B | $16.89B | · | $14.00B | $12.63B | $11.18B | |
| Goodwill | $85.48B | $91.27B | $91.27B | $78.15B | $79.12B | $79.55B | $79.75B | · | $38.45B | $38.25B | $38.11B | |
| Intangibles | $25.51B | $27.32B | $29.23B | $24.80B | $29.03B | $31.14B | $33.12B | $36.31B | $13.63B | $13.51B | $13.88B | |
| Other Non-current Assets | $7.11B | $4.79B | $4.66B | $4.62B | $4.71B | $4.62B | $4.60B | $4.53B | $1.42B | $1.49B | $1.44B | |
| Total Assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | $216.67B | $95.13B | $94.46B | $92.44B | |
| Accounts Payable | · | · | · | · | · | · | · | · | $8.86B | $7.95B | $7.49B | |
| Accrued Liabilities | $22.39B | $20.81B | $23.52B | $18.75B | $17.67B | $14.24B | $12.13B | $10.66B | $6.58B | $6.94B | $6.83B | |
| Short-term Debt | $0 | $2.12B | $200M | $0 | · | $0 | $0 | · | $1.28B | $1.87B | $0 | |
| Current Liabilities | $88.69B | $84.61B | $79.19B | $69.42B | $67.81B | $62.02B | $53.30B | $45.76B | $30.65B | $26.25B | $23.17B | |
| Capital Leases | $13.64B | $14.90B | $16.03B | $16.80B | $18.18B | $18.76B | $18.93B | $18.83B | $306M | · | · | |
| Deferred Tax | $3.83B | $3.81B | $4.31B | $4.02B | $6.27B | $6.79B | $7.29B | $7.74B | $3.00B | $4.21B | $4.22B | |
| Other Non-current Liabilities | $6.77B | $5.43B | $6.21B | $6.73B | $1.90B | $2.35B | $2.16B | $2.26B | $1.28B | $1.55B | $1.54B | |
| Total Liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B | $161.01B | $158.28B | $157.95B | $57.44B | · | · | |
| Long-term Debt | · | · | · | · | · | · | $68.48B | $72.61B | $27.00B | $25.70B | $27.50B | |
| Total Debt | $0 | $2.12B | $200M | · | · | · | $3.78B | · | $27.00B | $27.53B | $27.46B | |
| Common Stock | · | $18M | $18M | $18M | $17M | $17M | $17M | · | $17M | $17M | $17M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $32.08B | $31.62B | $30.95B | |
| Retained Earnings | $61.20B | $62.84B | $61.60B | $56.40B | $54.91B | $49.64B | $45.11B | $41.09B | $43.56B | $38.98B | $35.51B | |
| Treasury Stock | $36.79B | $36.82B | $33.84B | $31.86B | $28.17B | $28.18B | $28.23B | · | $37.80B | $33.45B | $28.89B | |
| AOCI | $406M | $-120M | $-297M | $-1.26B | $965M | $1.41B | $1.02B | · | $-165M | $-305M | $-358M | |
| Stockholders' Equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B | $69.39B | $63.86B | $58.40B | $37.69B | $36.83B | $37.20B | |
| Liabilities + Equity | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | · | $95.13B | $94.46B | $92.44B | |
| Shares Outstanding | 1,271,000,000 | 1,260,000,000 | 1,288,000,000 | 1,300,000,000 | 1,322,000,000 | 1,310,000,000 | 1,302,000,000 | · | 1,712,000,000 | 1,061,000,000 | 1,101,000,000 |
Arus Kas 19
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | · | $2.48B | $2.48B | $2.09B | |
| Stock-based Comp | $535M | $540M | $588M | $447M | $484M | $400M | $453M | · | $234M | $222M | $230M | |
| Deferred Tax | $102M | $-572M | $-676M | $-2.03B | $-402M | $-564M | $-649M | · | $-1.42B | $3M | $-234M | |
| Amort. of Intangibles | $2.00B | $2.00B | $1.90B | $1.80B | $2.20B | $2.30B | $2.40B | · | $817M | $795M | $611M | |
| Restructuring | · | · | · | · | · | · | · | · | $215M | · | · | |
| Other Non-cash | $3.63B | $-72M | $804M | $9.41B | $5.79B | $4.41B | $2.04B | · | $93M | · | · | |
| Operating Cash Flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | · | $8.01B | $10.14B | $8.54B | |
| CapEx | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | · | $1.92B | $2.22B | $2.37B | |
| Investing Cash Flow | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | · | $-2.88B | $-2.47B | $-13.42B | |
| Debt Issued | $3.97B | $7.91B | $10.90B | $0 | $987M | $9.96B | $3.74B | · | $0 | $3.46B | $14.80B | |
| Net Debt Issued | $340M | $3.14B | $7.73B | $-4.21B | $-9.27B | $-5.67B | $-4.60B | · | · | $-2.49B | $11.90B | |
| Stock Repurchased | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | · | $4.36B | $4.46B | $5.00B | |
| Net Stock Activity | $0 | $-3.02B | $-2.01B | $-3.50B | · | · | $0 | · | $-4.36B | $-4.46B | $-5.00B | |
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B | |
| Financing Cash Flow | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | · | $-6.75B | $-6.76B | $4.88B | |
| Net Change in Cash | $-172M | $359M | $-4.78B | $614M | $1.65B | $2.63B | $1.85B | · | $-1.62B | $912M | $-22M | |
| Taxes Paid | $2.17B | $1.70B | $3.52B | $4.12B | $3.19B | $2.93B | $2.72B | · | $2.91B | $3.06B | $3.27B | |
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | · | $6.09B | $7.84B | $6.04B | |
| Levered FCF | · | · | $8.40B | $11.76B | $13.85B | $11.29B | $8.15B | · | $5.24B | $7.18B | $5.52B |
Profitabilitas 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 15.4% | 16.3% | 17.3% | |
| Operating Margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% | 5.2% | 4.7% | · | 5.1% | 5.8% | 6.2% | |
| Net Margin | 0.44% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | · | 3.6% | 3.0% | 3.4% | |
| Pretax Margin | 0.53% | 1.7% | 3.1% | 1.8% | 3.6% | 3.6% | 3.5% | · | 4.5% | 4.9% | 5.6% | |
| EBITDA Margin | 2.3% | 3.5% | 5.1% | 3.7% | 6.1% | 6.8% | 6.4% | · | 6.5% | 5.8% | 6.2% | |
| ROA | 0.70% | 1.8% | 3.5% | 1.8% | 3.4% | 3.2% | 3.0% | · | 7.0% | 5.7% | 6.2% | |
| ROE | 2.4% | 6.1% | 11.3% | 5.7% | 10.9% | 10.8% | 10.8% | · | 17.8% | 14.4% | 13.9% | |
| ROIC | 5.0% | 8.2% | 13.4% | 8.1% | 13.3% | 14.8% | 13.1% | · | 11.8% | 9.9% | 8.9% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.2 | 1.3 | |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · | 0.1 | · | 0.7 | 0.7 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.7 | 0.7 | |
| Interest Coverage | · | · | 5.2 | 3.4 | 5.3 | 4.8 | 3.9 | · | 9.0 | 9.6 | 11.0 |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.2 | · | 1.9 | 1.9 | 1.8 | |
| Inventory Turnover | 11.8 | 11.4 | 11.7 | 10.7 | 9.7 | 9.1 | 9.3 | · | 10.4 | 10.3 | 9.8 | |
| Receivables Turnover | 10.5 | 10.4 | 11.4 | 12.5 | 12.7 | 13.0 | 13.8 | · | 14.6 | 14.8 | 14.2 |
Tingkat Pertumbuhan 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 8.5% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -62.0% | -43.4% | 98.5% | -45.9% | 10.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -24.7% | -15.3% | 5.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -23.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -61.7% | -44.7% | 93.5% | -46.1% | 11.5% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -25.7% | -16.8% | 5.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -24.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Net Income TTM | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| Market Cap | $100.87B | $56.56B | $101.70B | $121.15B | $136.38B | $89.47B | $96.73B | · | $73.52B | $83.72B | $107.64B | |
| Enterprise Value | $90.27B | $47.69B | $90.45B | · | · | · | $92.45B | · | $98.71B | $107.80B | $132.56B | |
| P/E | 57.1 | 12.3 | 12.2 | 28.6 | 17.1 | 12.5 | 14.6 | · | 11.3 | 16.1 | 21.1 | |
| P/S | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.7 | |
| P/B | 1.3 | 0.7 | 1.3 | 1.7 | 1.8 | 1.3 | 1.5 | · | 2.0 | 2.3 | 2.9 | |
| P / Cash Flow | 9.5 | 6.2 | 7.6 | 7.5 | 7.5 | 5.6 | 7.5 | · | 9.2 | 8.3 | 12.8 | |
| P / FCF | 12.9 | 8.9 | 9.8 | 9.0 | 8.7 | 6.7 | 9.3 | · | 12.1 | 10.7 | 17.8 | |
| EV / EBITDA | 9.7 | 3.6 | 5.0 | · | · | · | 5.7 | · | 8.2 | 10.4 | 14.0 | |
| EV / FCF | 11.6 | 7.5 | 8.7 | · | · | · | 8.9 | · | 16.2 | 13.7 | 21.9 | |
| EV / Revenue | 0.2 | 0.1 | 0.3 | · | · | · | 0.4 | · | 0.5 | 0.6 | 0.9 | |
| Dividend Yield | 3.4% | 6.0% | 3.1% | 2.4% | 1.9% | 2.9% | 2.7% | · | 2.8% | 2.2% | 1.5% | |
| Earnings Yield | 1.8% | 8.2% | 8.2% | 3.5% | 5.8% | 8.0% | 6.8% | · | 8.9% | 6.2% | 4.7% | |
| Payout Ratio | 192.1% | 73.1% | 37.5% | 70.1% | 33.2% | 36.5% | 39.2% | · | 30.9% | 34.6% | 30.1% | |
| Annual Payout | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | $94.59B | $97.71B | $95.43B | $91.23B | $88.44B | $93.81B | $89.76B | $88.92B | $85.28B | $83.85B | $81.16B | |
| Cost of Revenue | $58.86B | $55.44B | $59.06B | $57.05B | $54.01B | $51.06B | $55.27B | $52.95B | $50.00B | $48.07B | $57.42B | $54.69B | $53.54B | $51.45B | $51.73B | $50.37B | |
| Operating Expenses | $101.39B | $95.75B | $103.58B | $106.08B | $96.53B | $91.21B | $95.34B | $94.60B | $88.19B | $86.17B | $90.44B | $86.07B | $85.69B | $81.83B | $80.19B | $85.08B | |
| Operating Income | $4.70B | $4.68B | $2.11B | $-3.21B | $2.38B | $3.37B | $2.37B | $832M | $3.04B | $2.27B | $3.37B | $3.69B | $3.23B | $3.45B | $3.66B | $-3.92B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $716M | · | $693M | $686M | $589M | · | $566M | |
| Other Non-op | $31M | $32M | $29M | $26M | $29M | $28M | $25M | $25M | $24M | $25M | $22M | $22M | $22M | $22M | $43M | $41M | |
| Pretax Income | $3.98B | $3.94B | $1.35B | $-3.48B | $1.65B | $2.62B | $2.13B | $105M | $2.34B | $1.58B | $2.71B | $3.02B | $2.57B | $2.88B | $3.15B | $-4.44B | |
| Income Tax | $982M | $981M | $-1.57B | $508M | $634M | $835M | $503M | $34M | $569M | $456M | $658M | $754M | $656M | $737M | $818M | $-1.04B | |
| Net Income | $2.98B | $2.94B | $2.94B | $-3.98B | $1.02B | $1.78B | $1.64B | $87M | $1.77B | $1.11B | $2.05B | $2.26B | $1.90B | $2.14B | $2.33B | $-3.41B | |
| EPS (Basic) | $2.33 | $2.31 | $2.31 | $-3.13 | $0.81 | $1.41 | $1.31 | $0.07 | $1.41 | $0.88 | $1.59 | $1.76 | $1.48 | $1.66 | $1.78 | $-2.59 | |
| EPS (Diluted) | $2.31 | $2.30 | $2.31 | $-3.13 | $0.80 | $1.41 | $1.30 | $0.07 | $1.41 | $0.88 | $1.59 | $1.75 | $1.48 | $1.65 | $1.79 | $-2.59 | |
| Shares (Basic) | 1,279,000,000 | 1,273,000,000 | -2,529,000,000 | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | -2,516,000,000 | 1,259,000,000 | 1,256,000,000 | 1,260,000,000 | -2,568,000,000 | 1,287,000,000 | 1,283,000,000 | 1,283,000,000 | -2,628,000,000 | 1,315,000,000 | |
| Shares (Diluted) | 1,287,000,000 | 1,279,000,000 | -2,532,000,000 | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | -2,523,000,000 | 1,259,000,000 | 1,259,000,000 | 1,267,000,000 | -2,578,000,000 | 1,290,000,000 | 1,287,000,000 | 1,291,000,000 | -2,641,000,000 | 1,315,000,000 | |
| EBITDA | $5.83B | $5.79B | · | $-2.07B | $3.55B | $4.53B | · | $832M | $3.04B | $3.41B | · | $3.69B | $3.23B | $4.45B | · | $-3.93B |
Neraca 26
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B | $9.80B | $8.20B | $13.04B | $13.81B | $14.62B | $12.95B | $17.20B | |
| Short-term Investments | $2.63B | $2.26B | $2.15B | $2.13B | $2.39B | $2.58B | $2.41B | $2.81B | $3.75B | $3.29B | · | $3.15B | $3.08B | $3.10B | · | $2.79B | |
| Receivables | $40.31B | $40.99B | $39.78B | $43.86B | $40.65B | $39.62B | $36.47B | $36.18B | $32.38B | $32.22B | · | $32.93B | $29.55B | $28.33B | · | $26.32B | |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B | $16.35B | · | $17.95B | $17.29B | $18.26B | · | $18.06B | |
| Other Current Assets | $3.46B | $4.25B | $5.09B | $3.06B | $3.38B | $3.53B | $3.08B | $3.83B | $5.24B | $5.82B | · | $3.07B | $3.41B | $3.77B | · | $2.48B | |
| Current Assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B | $67.47B | · | $70.14B | $67.76B | $68.71B | · | $68.34B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $13.02B | $13.00B | $12.87B | · | $12.63B | |
| Goodwill | $85.48B | $85.48B | $85.48B | $85.48B | $91.20B | $91.20B | $91.27B | $91.27B | $91.27B | $91.27B | $91.27B | $91.26B | $91.26B | $84.06B | $78.15B | $78.09B | |
| Intangibles | $24.64B | $25.07B | $25.51B | $25.98B | $26.22B | $26.57B | $27.32B | $27.82B | $28.31B | $28.77B | · | $29.62B | $30.12B | $26.37B | · | $25.16B | |
| Other Non-current Assets | $7.43B | $7.42B | $5.12B | $5.16B | $5.21B | $5.23B | $4.79B | $4.76B | $4.80B | $4.80B | · | $4.83B | $4.85B | $4.82B | · | $4.85B | |
| Total Assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Accrued Liabilities | $22.48B | $22.26B | $22.39B | $23.41B | $23.10B | $22.37B | $20.81B | $20.17B | $21.16B | $22.35B | · | $22.57B | $22.83B | $21.52B | · | $19.42B | |
| Short-term Debt | · | · | $0 | $1.25B | $3.04B | $1.26B | $2.12B | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Current Liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | $88.96B | $84.61B | $84.63B | $81.39B | $83.32B | · | $81.55B | $79.21B | $75.05B | · | $72.41B | |
| Capital Leases | $12.98B | $13.33B | $13.64B | $14.01B | $14.33B | $14.59B | $14.90B | $15.26B | $15.54B | $15.74B | · | $16.44B | $16.61B | $16.57B | · | $17.17B | |
| Deferred Tax | $3.77B | $3.77B | $3.83B | $3.55B | $3.60B | $3.66B | $3.81B | $3.63B | $4.05B | $4.18B | · | $4.25B | $4.59B | $4.09B | · | $3.51B | |
| Other Non-current Liabilities | $6.11B | $6.71B | $4.78B | $4.76B | $4.78B | $5.42B | $5.43B | $5.48B | $5.53B | $6.21B | · | $6.24B | $6.32B | $6.67B | · | $6.77B | |
| Total Liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B | $175.59B | · | $176.80B | $177.07B | $167.75B | · | $160.20B | |
| Total Debt | · | · | · | $1.25B | $3.04B | $1.26B | · | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Common Stock | · | · | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | $18M | |
| Retained Earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | $63.77B | $62.84B | $62.04B | $62.80B | $61.87B | · | $60.34B | $58.87B | $57.75B | · | $54.57B | |
| Treasury Stock | $36.85B | $36.71B | $36.79B | $36.78B | $36.85B | $36.73B | $36.82B | $36.81B | $36.92B | $36.77B | · | $33.83B | $33.93B | $33.80B | · | $30.33B | |
| AOCI | $188M | $201M | $406M | $416M | $272M | $59M | $-120M | $209M | $-319M | $-341M | · | $-1.00B | $-858M | $-875M | · | $-1.61B | |
| Stockholders' Equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B | $73.97B | · | $74.34B | $72.73B | $71.38B | · | $70.68B | |
| Liabilities + Equity | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Shares Outstanding | 1,278,000,000 | 1,273,000,000 | 1,271,000,000 | 1,270,000,000 | 1,267,000,000 | 1,262,000,000 | 1,260,000,000 | 1,258,000,000 | 1,256,000,000 | 1,252,000,000 | · | 1,287,000,000 | 1,282,000,000 | 1,279,000,000 | · | 1,315,000,000 |
Arus Kas 17
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | $1.15B | $1.15B | $1.16B | $1.15B | $1.14B | $1.13B | $1.13B | $1.10B | $1.00B | $1.04B | $1.04B | |
| Stock-based Comp | $176M | $266M | $135M | $138M | $136M | $126M | $137M | $133M | $133M | $137M | $127M | $154M | $204M | $103M | $106M | $105M | |
| Amort. of Intangibles | $431M | $442M | $507M | $500M | $494M | $499M | $478M | $507M | $507M | $508M | $504M | $509M | $485M | $402M | $420M | $458M | |
| Other Non-cash | · | $-75M | · | · | · | $1.50B | · | · | · | $2.52B | · | · | · | $4.20B | · | · | |
| Operating Cash Flow | $6.34B | $4.25B | $3.39B | $796M | $1.90B | $4.56B | $1.86B | $-745M | $3.09B | $4.90B | $-2.64B | $2.72B | $5.91B | $7.44B | $-1.95B | $9.12B | |
| CapEx | $691M | $849M | $784M | $698M | $607M | $743M | $768M | $670M | $638M | $705M | $911M | $545M | $591M | $984M | $688M | $580M | |
| Investing Cash Flow | $-1.88B | $-874M | $-2.00B | $-2.09B | $-1.02B | $-762M | $-547M | $-3.35B | $-1.62B | $-2.09B | $-1.24B | $-771M | $-10.36B | $-8.51B | $-119M | $-805M | |
| Debt Issued | · | · | $0 | $3.97B | · | · | $2.95B | $0 | $4.96B | $0 | $0 | $0 | $4.95B | $5.95B | $0 | $0 | |
| Net Debt Issued | · | $-1.52B | · | · | · | $-743M | · | · | · | $-18M | · | · | · | $5.59B | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $-1M | $-3M | $3.03B | $-1M | $-3M | $-2M | $2.02B | $1.50B | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3.03B | · | · | · | $-2.02B | · | · | |
| Dividends Paid | $878M | $847M | $845M | $846M | $866M | $840M | $838M | $837M | $858M | $840M | $779M | $779M | $795M | $779M | $719M | $726M | |
| Financing Cash Flow | $-2.69B | $-2.32B | $-2.03B | $-1.38B | $806M | $-2.33B | $431M | $-1.59B | $1.25B | $-1.23B | $-972M | $-2.70B | $3.63B | $2.73B | $-2.19B | $-3.22B | |
| Net Change in Cash | $1.77B | $1.06B | $-640M | $-2.67B | $1.68B | $1.46B | $1.74B | $-5.68B | $2.71B | $1.58B | $-4.85B | $-752M | $-828M | $1.65B | $-4.26B | $5.10B | |
| Taxes Paid | $374M | $-337M | $998M | $305M | $725M | $138M | $274M | $700M | $666M | $63M | $908M | $837M | $1.70B | $75M | $1.05B | $1.18B | |
| Free Cash Flow | · | $3.40B | · | · | · | $3.81B | · | · | · | $4.20B | · | · | · | $6.45B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3.69B | · | · | · | $6.02B | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.4% | 4.7% | · | -3.1% | 2.4% | 3.6% | · | 0.87% | 3.3% | 2.6% | · | 4.1% | 3.6% | 4.0% | · | -4.8% | |
| Net Margin | 2.8% | 2.9% | · | -3.9% | 1.0% | 1.9% | · | 0.09% | 1.9% | 1.3% | · | 2.5% | 2.1% | 2.5% | · | -4.2% | |
| Pretax Margin | 3.8% | 3.9% | · | -3.4% | 1.7% | 2.8% | · | 0.11% | 2.6% | 1.8% | · | 3.4% | 2.9% | 3.4% | · | -5.5% | |
| EBITDA Margin | 5.5% | 5.8% | · | -2.0% | 3.6% | 4.8% | · | 0.87% | 3.3% | 3.9% | · | 4.1% | 3.6% | 5.2% | · | -4.8% | |
| ROA | 1.2% | 1.2% | · | -1.6% | 0.40% | 0.70% | · | 0.03% | 0.70% | 0.46% | · | 0.94% | 0.79% | 0.90% | · | -1.5% | |
| ROE | 3.8% | 3.8% | · | -5.4% | 1.3% | 2.4% | · | 0.12% | 2.4% | 1.5% | · | 3.1% | 2.6% | 2.9% | · | -4.7% | |
| ROIC | 4.4% | 4.5% | · | -5.0% | 1.8% | 2.9% | · | 0.74% | 3.1% | 2.1% | · | 3.7% | 3.3% | 3.6% | · | -4.2% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | 5.3 | 4.7 | 5.9 | · | -6.9 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Inventory Turnover | 3.4 | 3.2 | · | 3.1 | 3.2 | 3.0 | · | 3.0 | 3.0 | 2.8 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Receivables Turnover | 2.6 | 2.5 | · | 2.6 | 2.7 | 2.6 | · | 2.8 | 2.9 | 2.9 | · | 3.0 | 3.1 | 3.1 | · | 3.1 |
Valuasi (TTM) 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $408.31B | $396.80B | · | $391.80B | $380.17B | $369.69B | · | $364.86B | $358.36B | $352.40B | · | $345.12B | $335.99B | $323.90B | · | $312.42B | |
| Net Income TTM | $2.97B | $1.77B | · | $-1.09B | $4.66B | $4.75B | · | $5.23B | $7.04B | $7.41B | · | $2.89B | $3.66B | $4.11B | · | $3.58B | |
| Market Cap | $132.21B | $91.43B | · | $95.75B | $87.40B | $85.50B | · | $79.10B | $74.18B | $99.86B | · | $89.86B | $88.62B | $95.04B | · | $125.41B | |
| Enterprise Value | · | · | · | $85.76B | $76.26B | $74.11B | · | $70.22B | $57.92B | $89.49B | · | · | $72.74B | · | · | · | |
| P/E | 45.4 | 52.0 | · | -88.7 | 18.7 | 18.0 | · | 15.3 | 10.7 | 13.8 | · | 30.5 | 24.4 | 23.8 | · | 35.7 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| P/B | 1.7 | 1.2 | · | 1.3 | 1.1 | 1.1 | · | 1.1 | 1.0 | 1.4 | · | 1.2 | 1.2 | 1.3 | · | 1.8 | |
| P / Cash Flow | · | 21.5 | · | · | · | 18.8 | · | · | · | 20.4 | · | · | · | 12.8 | · | · | |
| P / FCF | · | 26.9 | · | · | · | 22.4 | · | · | · | 23.8 | · | · | · | 14.7 | · | · | |
| EV / EBITDA | · | · | · | -41.4 | 21.5 | 16.4 | · | 84.4 | 19.0 | 26.3 | · | · | 22.5 | · | · | · | |
| EV / FCF | · | · | · | · | · | 19.4 | · | · | · | 21.3 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | · | 0.2 | · | · | · | |
| Earnings Yield | 2.2% | 1.9% | · | -1.1% | 5.3% | 5.6% | · | 6.5% | 9.3% | 7.2% | · | 3.3% | 4.1% | 4.2% | · | 2.8% | |
| Payout Ratio | · | 28.8% | · | · | · | 47.2% | · | · | · | 75.5% | · | · | · | 36.5% | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Margin Operasi % | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| Laba Bersih | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| EPS Dilusian | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.0 | 0.0 | 0.0 | — | — |
| Rasio Lancar | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 |
| Rasio Cepat | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
- As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners
- What A Patient Holder Is Really Paying For CVS Health Stock
- Pembaruan Pasar: CVS, ETN, KMB, KO, PSX
- Jim Cramer tentang CVS: “Saya Berpendapat Bahwa Harganya Lebih Murah”
- Mengapa Saham CVS Melambung pada Rabu
- Jim Cramer Membuat Klaim Besar Tentang CVS Corporation (CVS)
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 2.290 pengaju · $77.0B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 319 (+131 vs Kuartal sebelumnya) | 93 (-97 vs Kuartal sebelumnya) | 783 (+85 vs Kuartal sebelumnya) | 714 (-58 vs Kuartal sebelumnya) | +184.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $8.618.974.924 | 83.315.369 | 11,20% | Saham |
| Capital World Investors | $7.753.834.783 | 74.951.955 | 10,08% | Saham |
| STATE STREET CORP | $6.236.318.558 | 60.283.408 | 8,10% | Saham |
| Dodge & Cox | $5.173.820.539 | 50.012.765 | 6,72% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $3.266.370.439 | 31.574.388 | 4,24% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.755.624.444 | 26.637.259 | 3,58% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $2.646.473.316 | 25.714.722 | 3,44% | Saham |
| Capital Research Global Investors | $2.516.851.376 | 24.329.151 | 3,27% | Saham |
| NORGES BANK | $1.866.126.481 | 18.038.922 | 2,42% | Saham |
| FMR LLC | $1.684.924.609 | 16.287.333 | 2,19% | Saham |
| Capital International Investors | $1.591.868.430 | 15.387.600 | 2,07% | Saham |
| Davis Selected Advisers | $1.227.594.458 | 11.865.916 | 1,60% | Saham |
| Clearbridge Investments, LLC | $878.119.687 | 8.488.349 | 1,14% | Saham |
| GQG Partners LLC | $822.989.370 | 7.955.411 | 1,07% | Saham |
| AMERIPRISE FINANCIAL INC | $761.355.564 | 7.357.966 | 0,99% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $741.242.940 | 7.165.229 | 0,96% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $643.180.166 | 6.217.304 | 0,84% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $524.415.257 | 5.069.263 | 0,68% | Saham |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $499.125.457 | 4.824.799 | 0,65% | Saham |
| CITADEL ADVISORS LLC | $493.765.609 | 4.772.988 | 0,64% | Saham |
| VIKING GLOBAL INVESTORS LP | $378.974.695 | 3.663.361 | 0,49% | Saham |
| Swiss National Bank | $371.195.152 | 3.588.160 | 0,48% | Saham |
| BlackRock, Inc. | $364.982.048 | 3.528.101 | 0,47% | Saham |
| RAYMOND JAMES FINANCIAL INC | $354.997.941 | 3.431.590 | 0,46% | Saham |
| National Pension Service | $352.166.145 | 3.404.216 | 0,46% | Saham |
| ROYAL BANK OF CANADA | $338.495.000 | 3.272.060 | 0,44% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $322.653.390 | 3.118.927 | 0,42% | Saham |
| GOLDMAN SACHS GROUP INC | $319.964.422 | 3.092.938 | 0,42% | Saham |
| Legal & General Group Plc | $315.302.980 | 3.047.878 | 0,41% | Saham |
| Holocene Advisors, LP | $310.524.210 | 3.001.684 | 0,40% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $300.309.006 | 2.902.944 | 0,39% | Saham |
| CITADEL ADVISORS LLC | $299.591.200 | 2.896.000 | 0,39% | Opsi beli |
| Sumitomo Mitsui Trust Group, Inc. | $298.855.050 | 2.888.884 | 0,39% | Saham |
| Vanguard Global Advisers, LLC | $295.578.375 | 2.857.210 | 0,38% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $295.497.373 | 2.856.427 | 0,38% | Saham |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | $280.502.160 | 2.712.000 | 0,36% | Saham |
| CITADEL ADVISORS LLC | $267.076.865 | 2.581.700 | 0,35% | Opsi jual |
| BNP PARIBAS FINANCIAL MARKETS | $261.748.880 | 2.530.197 | 0,34% | Saham |
| BANK OF AMERICA CORP /DE/ | $249.417.276 | 2.410.993 | 0,32% | Saham |
| PRIMECAP MANAGEMENT CO/CA/ | $246.778.944 | 2.385.490 | 0,32% | Saham |
| RHUMBLINE ADVISERS | $246.744.475 | 2.385.158 | 0,32% | Saham |
| FRANKLIN RESOURCES INC | $238.592.528 | 2.306.356 | 0,31% | Saham |
| California Public Employees Retirement System | $233.879.967 | 2.260.802 | 0,30% | Saham |
| ALLIANCEBERNSTEIN L.P. | $232.194.060 | 3.233.000 | 0,30% | Saham |
| JANE STREET GROUP, LLC | $231.055.575 | 2.233.500 | 0,30% | Opsi jual |
| CANADA PENSION PLAN INVESTMENT BOARD | $230.615.292 | 2.229.244 | 0,30% | Saham |
| Canoe Financial LP | $226.952.024 | 2.193.833 | 0,29% | Saham |
| MILLENNIUM MANAGEMENT LLC | $223.951.974 | 2.164.833 | 0,29% | Saham |
| VANGUARD GROUP INC | $222.935.255 | 2.809.164 | 0,29% | Saham |
| UBS Group AG | $221.527.830 | 2.141.400 | 0,29% | Opsi beli |
| Brandywine Global Investment Management, LLC | $216.103.153 | 2.723.074 | 0,28% | Saham |
| Robeco Institutional Asset Management B.V. | $207.806.227 | 2.008.760 | 0,27% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $205.293.939 | 1.984.475 | 0,27% | Saham |
| Point72 Asset Management, L.P. | $202.868.760 | 1.961.032 | 0,26% | Saham |
| JANUS HENDERSON GROUP PLC | $200.732.734 | 2.794.942 | 0,26% | Saham |
| JANE STREET GROUP, LLC | $190.306.620 | 1.839.600 | 0,25% | Opsi beli |
| JONES FINANCIAL COMPANIES LLLP | $186.577.346 | 1.788.167 | 0,24% | Saham |
| Assenagon Asset Management S.A. | $183.757.718 | 1.776.295 | 0,24% | Saham |
| MACKENZIE FINANCIAL CORP | $177.786.480 | 1.718.574 | 0,23% | Saham |
| Hamlin Capital Management, LLC | $177.686.548 | 1.717.608 | 0,23% | Saham |
| Alyeska Investment Group, L.P. | $174.358.768 | 1.685.440 | 0,23% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $169.576.171 | 1.639.209 | 0,22% | Saham |
| LPL Financial LLC | $160.912.185 | 1.555.458 | 0,21% | Saham |
| PRUDENTIAL FINANCIAL INC | $156.319.985 | 1.511.068 | 0,20% | Saham |
| GOLDMAN SACHS GROUP INC | $153.033.585 | 1.479.300 | 0,20% | Opsi beli |
| Quantinno Capital Management LP | $150.197.267 | 1.451.882 | 0,20% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $149.812.359 | 1.448.162 | 0,19% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $146.277.266 | 1.413.990 | 0,19% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $143.800.879 | 1.390.052 | 0,19% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $143.310.113 | 1.385.308 | 0,19% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $135.669.704 | 1.889.024 | 0,18% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $133.185.771 | 1.287.441 | 0,17% | Saham |
| BARCLAYS PLC | $130.962.631 | 1.265.951 | 0,17% | Saham |
| UBS Group AG | $130.742.593 | 1.263.824 | 0,17% | Saham |
| MACQUARIE GROUP LTD | $130.222.860 | 1.258.800 | 0,17% | Saham |
| Patient Capital Management, LLC | $127.813.106 | 1.235.505 | 0,17% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $125.407.000 | 1.212.248 | 0,16% | Saham |
| Maple Rock Capital Partners Inc. | $123.932.686 | 1.197.996 | 0,16% | Saham |
| BANK OF MONTREAL /CAN/ | $120.915.774 | 1.168.833 | 0,16% | Saham |
| Qube Research & Technologies Ltd | $118.745.083 | 1.147.850 | 0,15% | Saham |
| TD Asset Management Inc | $117.174.298 | 1.132.666 | 0,15% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $114.781.970 | 1.108.148 | 0,15% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $114.360.975 | 1.105.471 | 0,15% | Saham |
| AVIVA PLC | $113.872.588 | 1.100.750 | 0,15% | Saham |
| Integral Health Asset Management, LLC | $113.795.000 | 1.100.000 | 0,15% | Saham |
| LETKO, BROSSEAU & ASSOCIATES INC | $113.305.164 | 1.095.265 | 0,15% | Saham |
| TRUIST FINANCIAL CORP | $112.799.640 | 1.090.378 | 0,15% | Saham |
| Woodline Partners LP | $112.125.214 | 1.083.859 | 0,15% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $111.580.653 | 1.078.595 | 0,14% | Saham |
| STOREBRAND ASSET MANAGEMENT AS | $111.494.582 | 1.077.763 | 0,14% | Saham |
| NORDEA INVESTMENT MANAGEMENT AB | $110.986.994 | 1.076.081 | 0,14% | Saham |
| BANK OF NOVA SCOTIA | $103.790.874 | 1.003.295 | 0,13% | Saham |
| Capital International, Inc./CA/ | $102.952.716 | 995.193 | 0,13% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $100.146.711 | 970.080 | 0,13% | Saham |
| Walleye Trading LLC | $98.691.300 | 954.000 | 0,13% | Opsi beli |
| Walleye Trading LLC | $98.049.910 | 947.800 | 0,13% | Opsi jual |
| Korea Investment CORP | $97.590.385 | 943.358 | 0,13% | Saham |
| JENNISON ASSOCIATES LLC | $97.539.798 | 942.869 | 0,13% | Saham |
| SEB Asset Management AB | $96.760.081 | 935.333 | 0,13% | Saham |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $91.910.670 | 888.455 | 0,12% | Saham |
Orang dalam perusahaan 86 orang dalam · 48 pejabat · 41 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| David J. Joyner | President, CEO and Chair | 1 April 2026 F | 70.349 | 0 | 0 | $0 |
| Karen S Lynch | President and CEO | 1 April 2024 A | 74.687 | 0 | 0 | $0 |
| Brian Newman | EVP, Chief Financial Officer | 31 Mei 2026 F | 3.008 | 0 | 0 | $0 |
| Thomas F. Cowhey | EVP and CFO | 1 April 2025 A | 41.109 | 0 | 0 | $0 |
| Shawn M Guertin | EVP & Chief Financial Officer | 1 April 2023 A | 34.706 | 0 | 0 | $0 |
| Eva C Boratto | EVP & CFO | 4 Mei 2021 S | 115.331 | 0 | 0 | $0 |
| David M Denton | EVP and CFO | 29 Nov. 2018 S | 403 | 0 | 0 | $0 |
| David B Rickard | Chief Financial Officer | 14 Des. 2009 M | 207.179 | 0 | 0 | $0 |
| Howard A Mclure | President, Caremark Pharm Serv | 2 Nov. 2009 M | 0 | 0 | 0 | $0 |
| Jonathan C Roberts | EVP & Chief Operating Officer | 1 April 2022 A | 426.025 | 0 | 0 | $0 |
| James David Clark | SVP, Cont & Chief Acct Officer | 26 Juni 2026 F | 27.606 | 0 | 0 | $0 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | 31 Mei 2026 F | 9.557 | 0 | 0 | $0 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 8 Mei 2026 S | 10.133 | 0 | 1 | $-6.230.379 |
| Prem S Shah | EVP and Group President | 31 Maret 2026 A | 64.356 | 0 | 0 | $0 |
| Heidi B Capozzi | EVP and Chief People Officer | 31 Maret 2026 A | 13.023 | 3 | 0 | $4.588 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 31 Maret 2026 A | 33.421 | 0 | 0 | $0 |
| Steven H Nelson | EVP and President, Aetna | 31 Maret 2026 A | 2.900 | 1 | 0 | $1.289 |
| Sreekanth K Chaguturu | EVP and Chief Medical Officer | 1 April 2024 A | 23.666 | 0 | 0 | $0 |
| Laurie P. Havanec | EVP and Chief People Officer | 1 April 2024 A | 9.426 | 0 | 0 | $0 |
| Brian A Kane | EVP/President, Aetna | 1 April 2024 A | 12.569 | 0 | 0 | $0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 1 April 2023 A | 35.068 | 0 | 0 | $0 |
| Michelle A Peluso | EVP and Co-President of Retail | 1 April 2023 A | 124.383 | 0 | 0 | $0 |
| Thomas M Moriarty | EVP & General Counsel | 31 Des. 2022 F | 315.273 | 0 | 0 | $0 |
| Alan Lotvin | EVP&President-PharmacyServices | 4 Agu 2022 M | 109.183 | 0 | 0 | $0 |
| Troyen A Brennan | EVP and Chief Medical Officer | 3 April 2022 F | 232.676 | 0 | 0 | $0 |
| Neela Montgomery | EVP and Pres., Pharmacy/Retail | 1 April 2021 A | 29.502 | 0 | 0 | $0 |
| Lisa Bisaccia | Former EVP & Chief HR Officer | 1 April 2021 F | 66.417 | 0 | 0 | $0 |
| Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | 28 Feb. 2021 F | 25.657 | 0 | 0 | $0 |
| Jonathan E. Mayhew | EVP - Transformation | 2 Des. 2020 F | 6.855 | 0 | 0 | $0 |
| Derica W Rice | EVP & President, CVS Caremark | 28 Feb. 2020 F | 26.827 | 0 | 0 | $0 |
| Kevin Hourican | EVP & President, CVS Pharmacy | 1 April 2019 A | 15.237 | 0 | 0 | $0 |
| Helena Foulkes | EVP & President-CVS Pharmacy | 16 Feb. 2018 M | 45.107 | 0 | 0 | $0 |
| Robert O. Kraft | EVP and President - Omnicare | 3 April 2017 A | 92.360 | 0 | 0 | $0 |
| Andrew Sussman | EVP, Clinical Services | 3 April 2017 A | 16.433 | 0 | 0 | $0 |
| Stephen J Gold | EVP & CIO | 3 April 2017 A | 46.818 | 0 | 0 | $0 |
| Per Gh Lofberg | EVP | 2 Jan. 2015 M | 23.419 | 0 | 0 | $0 |
| Mark Cosby | EVP & President-CVS/pharmacy | 30 Sep. 2013 M | 45.955 | 0 | 0 | $0 |
| Laird Daniels | SVP, Cont & Chief Acct Officer | 1 April 2013 A | 17.845 | 0 | 0 | $0 |
| Douglas A Sgarro | EVP and CLO | 11 Mei 2012 M | 214 | 0 | 0 | $0 |
| Stuart M Mcguigan | SVP and CIO | 16 Maret 2012 M | 10.967 | 0 | 0 | $0 |
| Thomas M Ryan | Non-Executive Chairman | 3 April 2011 F | 1.156.702 | 0 | 0 | $0 |
| Sara Finley | SVP, Gen Counsel | 18 Feb. 2011 F | 29.053 | 0 | 0 | $0 |
| Michael V Ferdinandi | Senior Vice President | 19 Agu 2009 S | 16.021 | 0 | 0 | $0 |
| Paula A Price | Controller | 12 Feb. 2008 A | 16.498 | 0 | 0 | $0 |
| Edwin M Crawford | Chairman | 29 Okt. 2007 A | 135.572 | 0 | 0 | $0 |
| William R Spalding | EVP Caremark Pharmacy Services | 18 Juni 2007 M | 182 | 0 | 0 | $0 |
| Gregory S Weishar | Vice President | 3 April 2006 A | 30.161 | 0 | 0 | $0 |
| Larry D Solberg | Senior Vice President | 16 Feb. 2006 A | 5.978 | 0 | 0 | $0 |
| ROBBINS LARRY | Direktur | 21 Mei 2026 S | 4.824.799 | 0 | 8 | $-352.750.556 |
| Fernando Aguirre | Direktur | 21 Mei 2026 D | 10.513 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| CVS Caremark Corporation | 7 Jan. 2011 | — | Pengajuan awal | M&A / penjualan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 218 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IHF · iShares Trust | 13,66% | 1.756.753 SH | 8 Agu 2026 | Harian |
| ROPE · EA Series Trust | 5,27% | 4.922 NS | 29 Mei 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 4,57% | 636.042 NS | 30 April 2026 | N-PORT |
| IYK · iShares Trust | 4,22% | 624.816 SH | 8 Agu 2026 | Harian |
| GEND · Spinnaker ETF Series | 3,66% | 1.968 NS | 30 April 2026 | N-PORT |
| PEZ · Invesco Exchange-Traded Fund Trust | 3,42% | 8.210 SH | 8 Agu 2026 | Harian |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,71% | 3.618 NS | 30 April 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,58% | 79.142 NS | 31 Mei 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 2,33% | 158.312 NS | 30 April 2026 | N-PORT |
| SDOG · ALPS ETF Trust | 2,25% | 342.879 NS | 31 Mei 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 2,16% | 4.706.232 NS | 30 April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 2,15% | 12.078 NS | 30 April 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,95% | 2.024.890 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 1,94% | 3.824.297 SH | 8 Agu 2026 | Harian |
| FXG · First Trust Exchange-Traded AlphaDE… | 1,89% | 55.579 NS | 30 April 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,88% | 334.242 SH | 8 Agu 2026 | Harian |
| SPDV · ETF Series Solutions | 1,86% | 20.100 NS | 30 April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,71% | 585.200 NS | 30 April 2026 | N-PORT |
| RXL · ProShares Trust | 1,67% | 13.266 NS | 31 Mei 2026 | N-PORT |
| IXJ · iShares Trust | 1,55% | 670.400 SH | 8 Agu 2026 | Harian |
| REVS · Columbia ETF Trust I | 1,55% | 52.621 NS | 30 April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,53% | 25.368 NS | 30 April 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,48% | 120.955 SH | 8 Agu 2026 | Harian |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,45% | 19.889 SH | 8 Agu 2026 | Harian |
| PWV · Invesco Exchange-Traded Fund Trust | 1,40% | 261.212 SH | 8 Agu 2026 | Harian |
| VLUE · iShares Trust | 1,38% | 1.353.743 SH | 8 Agu 2026 | Harian |
| DVY · iShares Trust | 1,37% | 3.341.969 SH | 8 Agu 2026 | Harian |
| ITAN · EA Series Trust | 1,36% | 13.295 NS | 29 Mei 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,30% | 27.039 NS | 31 Maret 2026 | N-PORT |
| GMOV · GMO ETF Trust | 1,21% | 12.118 NS | 31 Mei 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 1,17% | 41.394.000 | 8 Agu 2026 | Harian |
| GURU · Global X Funds | 1,17% | 8.187 NS | 30 April 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 1,13% | 16.706 NS | 31 Mei 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,12% | 830 NS | 31 Mei 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 1,11% | 31.567.000 | 8 Agu 2026 | Harian |
| CVAR · ETF Opportunities Trust | 1,01% | 4.716 NS | 30 April 2026 | N-PORT |
| VCEB · VANGUARD WORLD FUND | 0,99% | 12.250.700 PA | 8 Agu 2026 | Harian |
| CGCV · Capital Group Conservative Equity E… | 0,99% | 189.872 NS | 31 Mei 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,98% | 27.132 NS | 30 April 2026 | N-PORT |
| ABCS · EA Series Trust | 0,98% | 1.219 NS | 29 Mei 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 2.025 NS | 30 April 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,95% | 77.895 SH | 8 Agu 2026 | Harian |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,92% | 267.202 SH | 8 Agu 2026 | Harian |
| FNDX · SCHWAB STRATEGIC TRUST | 0,91% | 2.553.383 NS | 31 Mei 2026 | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0,91% | 98.192.000 PA | 8 Agu 2026 | Harian |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,88% | 87.427 SH | 8 Agu 2026 | Harian |
| AKAF · ETF Series Solutions | 0,84% | 271 NS | 31 Mei 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,83% | 120.850 NS | 31 Mei 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,81% | 529.096 NS | 30 April 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,81% | 10.773 NS | 30 April 2026 | N-PORT |